DAVID W DAWSON, MD
Medical Practice at Le Conte Ave, Los Angeles, CA
License number
California A74315
Category
Medical Practice
Type
Anatomic Pathology
Address
Address
10833 Le Conte Ave, Los Angeles, CA 90095
Phone
(310) 794-8285
Personal information
See more information about DAVID W DAWSON at radaris.comName
Address
Phone
5111 Stratford Cir, La Palma, CA 90623
5007 Regency Dr, Rocklin, CA 95677
4481 E Sierra Madre Ave, Fresno, CA 93726
495 Castle Dr, Santa Cruz, CA 95065
49 Amherst Ave, Menlo Park, CA 94025
Professional information
See more information about DAVID W DAWSON at trustoria.com
Owner At Promus Equity Partners
Owner At Promus Equity Partners
Position:
Owner at Promus Equity Partners, CEO at Promus Equity Partners
Location:
Greater Los Angeles Area
Industry:
Investment Banking
Work:
Promus Equity Partners
-
Owner
Promus Equity Partners
since 2009
-
CEO
Education:
Utah State University - Jon M. Huntsman School of Business 1997 - 1999
BS, Management Science
BS, Management Science
Contract Manager At Mdia - Medical Diagnostic Associates
Contract Manager At Mdia - Medical Diagnostic Associates
Position:
Contract Manager at MDIA - Medical Diagnostic Associates
Location:
Greater Los Angeles Area
Industry:
Hospital & Health Care
Work:
MDIA - Medical Diagnostic Associates
since Apr 2012
-
Contract Manager
Solatube International, Inc.
- Vista, CA Feb 2007 - Jan 2012
-
Inside Sales Representative
Pick Up Stix
- Greater San Diego Area Jun 2005 - Feb 2007
-
Assistant Manager
Automobile Club of Southern California
- San Diego, CA Jun 2002 - Jun 2005
-
Service Recovery Team Lead
Education:
San Diego Mesa College
Skills:
Sales Management, Lighting Control, Account Management, Salesforce.com, New Business Development, Sales, Marketing Strategy, Business Development, Green Building, Contract Negotiation, Product Marketing, Customer Service, Energy Efficiency, Lighting Design, Negotiation, Team Building, Product Development, Recruiting, Training, Strategic Planning
Vp, Stage Wright Inc, Theatrical Services For Education
Vp, Stage Wright Inc, Theatrical Services For Education
Location:
Greater Los Angeles Area
Industry:
Primary/Secondary Education
Work:
Paramount Pictures
Sep 1985 - Oct 2011
-
Exec Dir, Planning & Development
I.A.T.S.E. Local 44
1981 - 2011
-
Property Craftsman
Los Angeles Unified School District
- East Los Angeles 1975 - 1978
-
Instructor (Substitute), K through 9
Montebello School District
- Montebello, CA 1975 - 1978
-
Instructor (Substitute), K through 9
United States Air Force
- Anchorage, AK and Klamath Falls, OR 1968 - 1972
-
Communications Specialist - E3
Education:
University of California, Los Angeles 1974 - 1975
Teaching Credential, Education K-9 California State University-Los Angeles 1972 - 1975
B.A., Theatre Arts Los Angeles City College 1966 - 1968
A.A., Theatre Arts
Teaching Credential, Education K-9 California State University-Los Angeles 1972 - 1975
B.A., Theatre Arts Los Angeles City College 1966 - 1968
A.A., Theatre Arts
Skills:
AutoCAD, MS Office Suite, Graphic Design, Microsoft Office, Illustrator, Entertainment, Adobe Creative Suite, Television
Interests:
Arts and Music, American History, Health, Science, Trading/Investment, Fine Food & Cooking, Comedy (Literature & Performance), Writing, Advertising, Travel, Classic Cinema and Theatre. Carpentry, Stringed Instruments, History, Science Fiction, Pomegranates, Macadamias, Avocados, did I say beer? mmmmm
Honor & Awards:
Ancient Aliens - Galaxy 63e9(: System 56: "Legion Award" [Given to those aware they are not alone in the universe: but neither so freaked out by it, or so consumed by it that they forget to live their own lives."]
David Wayne Dawson, Los Angeles CA
David Wayne Dawson, Los Angeles CA
Specialties:
Anatomic Pathology, Anatomic Pathology & Clinical Pathology, Clinical Pathology/Laboratory Medicine
Work:
Ucla Pathology& Lab Medicine
10833 Le Conte Ave, Los Angeles, CA 90095
10833 Le Conte Ave, Los Angeles, CA 90095
Education:
Northwestern University (1999)
President At Dawson Financial, Inc.
President At Dawson Financial, Inc.
Position:
President at Dawson Financial, Inc.
Location:
Greater Los Angeles Area
Industry:
Financial Services
Work:
Dawson Financial, Inc.
-
President
David W Dawson, Los Angeles CA
David W Dawson, Los Angeles CA
Specialties:
Pathologist
Address:
10833 Le Conte Ave, Los Angeles, CA 90095
Education:
Doctor of Medicine
Board certifications:
American Board of Pathology Certification in Anatomic Pathology (Pathology)
Methods And Compositions For Inhibiting Angiogenesis
Methods And Compositions For Inhibiting Angiogenesis
US Patent:
6797691, Sep 28, 2004
Filed:
Jun 23, 2000
Appl. No.:
09/603478
Inventors:
David W. Dawson - Los Angeles CA
Paul R. Gillis - San Francisco CA
Olga Volpert - Wilmette IL
Susan E. Crawford - Burr Ridge IL
Veronica M. Stellmach - Chicago IL
Paul R. Gillis - San Francisco CA
Olga Volpert - Wilmette IL
Susan E. Crawford - Burr Ridge IL
Veronica M. Stellmach - Chicago IL
Assignee:
Northwestern University - Evanston IL
International Classification:
A61K 3816
US Classification:
514 2, 514 21
Abstract:
The present invention provides a method of inhibiting angiogenesis within a tissue by providing exogenous PEDF to cells associated with the tissue. The presence of exogenous PEDF inhibits angiogenesis within the tissue, in part by interfering with the ability of vascular endothelia to expand within the tissue. The invention also provides a method for determining the severity of a tumor by assaying for the presence of PEDF within the tumor. The invention further provides a method of inhibiting endothelial cell migration, a method of stimulating the growth of hair in a mammal, a method for inhibiting the growth of a tumor, a method of inducing differentiation of a neuroblastoma cell, a method of slowing the growth of a neuroblastoma cell, and method of treating ischemic retinopathy in a mammal. To facilitate the inventive methods, the present invention provides pharmaceutical compositions including sources of PEDF.
Methods And Compositions For Inhibiting Angiogenesis
Methods And Compositions For Inhibiting Angiogenesis
US Patent:
6919309, Jul 19, 2005
Filed:
Jan 14, 2003
Appl. No.:
10/342243
Inventors:
Noël P. Bouck - Occidental CA, US
David W. Dawson - Los Angeles CA, US
Paul R. Gillis - San Francisco CA, US
Olga Volpert - Wilmette IL, US
Susan E. Crawford - Burr Ridge IL, US
Veronica M. Stellmach - Chicago IL, US
David W. Dawson - Los Angeles CA, US
Paul R. Gillis - San Francisco CA, US
Olga Volpert - Wilmette IL, US
Susan E. Crawford - Burr Ridge IL, US
Veronica M. Stellmach - Chicago IL, US
Assignee:
Northwestern University - Evanston IL
International Classification:
A61K038/16
US Classification:
514 2, 514 21, 424574, 424537, 424571
Abstract:
The present invention provides a method of inhibiting angiogenesis within a tissue by providing exogenous PEDF to cells associated with the tissue. The presence of exogenous PEDF inhibits angiogenesis within the tissue, in part by interfering with the ability of vascular endothelia to expand within the tissue. The invention also provides a method for determining the severity of a tumor by assaying for the presence of PEDF within the tumor. The invention further provides a method of inhibiting endothelial cell migration, a method of stimulating the growth of hair in a mammal, a method for inhibiting the growth of a tumor, a method of inducing differentiation of a neuroblastoma cell, a method of slowing the growth of a neuroblastoma cell, and method of treating ischemic retinopathy in a mammal. To facilitate the inventive methods, the present invention provides pharmaceutical compositions including sources of PEDF.
Methods And Compositions For Inhibiting Angiogenesis
Methods And Compositions For Inhibiting Angiogenesis
US Patent:
7105496, Sep 12, 2006
Filed:
Jun 25, 2003
Appl. No.:
10/603387
Inventors:
Noël P. Bouck - Occidental CA, US
David W. Dawson - Los Angeles CA, US
Paul R. Gillis - Chicago IL, US
Olga Volpert - Wilmette IL, US
Susan E. Crawford - Burr Ridge IL, US
Veronica M. Stellmach - Chicago IL, US
David W. Dawson - Los Angeles CA, US
Paul R. Gillis - Chicago IL, US
Olga Volpert - Wilmette IL, US
Susan E. Crawford - Burr Ridge IL, US
Veronica M. Stellmach - Chicago IL, US
Assignee:
Northwestern University - Evanston IL
International Classification:
A61K 48/00, C12N 15/63, C12N 15/85
US Classification:
514 44, 4353201, 435325
Abstract:
The present invention provides a method of inhibiting angiogenesis within a tissue by providing exogenous PEDF to cells associated with the tissue. The presence of exogenous PEDF inhibits angiogenesis within the tissue, in part by interfering with the ability of vascular endothelia to expand within the tissue. The invention also provides a method for determining the severity of a tumor be assaying for the presence of PEDF within the tumor. To facilitate the inventive methods, the present invention provides pharmaceutical compositions including sources of PEDF.
Methods And Compositions For Inhibiting Angiogenesis
Methods And Compositions For Inhibiting Angiogenesis
US Patent:
7723313, May 25, 2010
Filed:
Jul 26, 2006
Appl. No.:
11/494363
Inventors:
Noel P. Bouck - Occidental CA, US
David W. Dawson - Los Angeles CA, US
Paul R. Gillis - San Francisco CA, US
Olga Volpert - Wilmette IL, US
Susan E. Crawford - Burr Ridge IL, US
Veronica M. Stellmach - Chicago IL, US
David W. Dawson - Los Angeles CA, US
Paul R. Gillis - San Francisco CA, US
Olga Volpert - Wilmette IL, US
Susan E. Crawford - Burr Ridge IL, US
Veronica M. Stellmach - Chicago IL, US
Assignee:
Northwestern University - Chicago IL
International Classification:
A61K 48/00, C12N 15/85
US Classification:
514 44, 435325, 4353201
Abstract:
The present invention provides a method of inhibiting angiogenesis within a tissue by providing exogenous PEDF to cells associated with the tissue. The presence of exogenous PEDF inhibits angiogenesis within the tissue, in part by interfering with the ability of vascular endothelia to expand within the tissue. The invention also provides a method for determining the severity of a tumor be assaying for the presence of PEDF within the tumor. To facilitate the inventive methods, the present invention provides pharmaceutical compositions including sources of PEDF.